Success Metrics

Clinical Success Rate
88.6%

Based on 31 completed trials

Completion Rate
89%(31/35)
Active Trials
7(13%)
Results Posted
39%(12 trials)
Terminated
4(8%)

Phase Distribution

Ph not_applicable
12
23%
Ph phase_2
8
15%
Ph phase_4
17
33%
Ph phase_3
10
19%
Ph phase_1
3
6%

Phase Distribution

3

Early Stage

8

Mid Stage

27

Late Stage

Phase Distribution50 total trials
Phase 1Safety & dosage
3(6.0%)
Phase 2Efficacy & side effects
8(16.0%)
Phase 3Large-scale testing
10(20.0%)
Phase 4Post-market surveillance
17(34.0%)
N/ANon-phased studies
12(24.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.8%

31 of 37 finished

Non-Completion Rate

16.2%

6 ended early

Currently Active

7

trials recruiting

Total Trials

52

all time

Status Distribution
Active(10)
Completed(31)
Terminated(6)
Other(5)

Detailed Status

Completed31
Recruiting7
unknown5
Terminated4
Not yet recruiting3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
52
Active
7
Success Rate
88.6%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (6.0%)
Phase 28 (16.0%)
Phase 310 (20.0%)
Phase 417 (34.0%)
N/A12 (24.0%)

Trials by Status

completed3160%
not_yet_recruiting36%
recruiting713%
unknown510%
terminated48%
withdrawn24%

Recent Activity

Clinical Trials (52)

Showing 20 of 52 trialsScroll for more
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Recruiting
NCT02309346Phase 4

Clindamycin Once a Day in Septic Abortion

Completed
NCT06494072Phase 4

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07267013Phase 2

Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)

Not Yet Recruiting
NCT01722708Not Applicable

Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies

Completed
NCT05137119Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting
NCT05846399Phase 4

CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)

Recruiting
NCT00642980Phase 4

Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis

Completed
NCT04104178Phase 3

Optimal Treatment of MRSA Throat Carriers

Completed
NCT04502095Phase 4

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Completed
NCT05899140Phase 4

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

Recruiting
NCT06702345Not Applicable

Clostridioides Difficile Controlled Human Infection Model

Not Yet Recruiting
NCT02814916Phase 3

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Completed
NCT03261830Phase 4

Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)

Completed
NCT06422221Phase 4

An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures

Not Yet Recruiting
NCT06172010Phase 4

Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

Recruiting
NCT06126263

Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections

Unknown
NCT02579161Phase 3

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

Completed
NCT05166746Phase 2

The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
52